跳至主要内容
临床试验/NL-OMON50733
NL-OMON50733已完成不适用

Planned vs. Actual Acetabular Cup Position in Total Hip Arthroplasty with Standard Instrumentation and Technique - DSJ_15010: Cup Position in THA with Standard Instruments

Medical Device Business Services, Inc. (DePuy Synthes)0 个研究点目标入组 54 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
54

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1) All devices are to be used according to the approved indications
  • 2) The patient is undergoing a standard of care hip replacement with the
  • Pinnacle cup and a Corail, Summit or Actis stem via the posterolateral,
  • anterolateral, or direct lateral approach with the patient in the lateral
  • decubitus position.
  • 3) Individuals who are able to speak, read, and comprehend the Informed Consent
  • Document and willing and able to provide informed patient consent for
  • participation in the study and have authorized the transfer of his/her
  • information to DePuy Synthes.
  • 4) Individuals who are willing and able to complete follow-up as specified by
  • the study protocol.
  • 5) Individuals who are willing and able to complete the Subject Hip Outcomes
  • questionnaires (i.e., FJS-12, EQ-5D-5L and Hip Evaluation) as specified by the
  • study protocol.
  • 6) Individuals who are not bedridden.
  • 7) Individuals who are a minimum age of 21 years at the time of consent.

排除标准

  • 1) Active local or systemic infection.
  • 2) Loss of musculature, neuromuscular compromise or vascular deficiency in the
  • affected limb rendering the procedure unjustified.
  • 3) Poor bone quality, such as osteoporosis, where, in the surgeon*s opinion,
  • there could be considerable migration of the prosthesis or a significant chance
  • of fracture of the femoral shaft and/or the lack of adequate bone to support
  • the implant(s).
  • 4) Charcot*s or Paget*s disease.
  • 5) The Subject is a woman who is pregnant or lactating.
  • 6) Subject had a contralateral amputation.
  • 7) Previous partial hip replacement in affected hip.
  • 8) Subject has participated in a clinical investigation with an investigational
  • product (drug or device) in the last three months.
  • 9) Contralateral hip was replaced less than 6 months prior to surgery date
  • 10) Subject is currently involved in any personal injury litigation,
  • medical-legal or worker*s compensation claims.
  • 11) Subject was diagnosed and is taking prescription medications to treat a
  • muscular disorder that limits mobility due to severe stiffness and pain such as
  • fibromyalgia or polymyalgia.
  • 12) Subject has a medical condition with less than 2 years of life expectancy.
  • 13) Subject, in the opinion of the Investigator, is a drug or alcohol abuser or
  • has a psychological disorder that could affect their ability to complete
  • patient reported questionnaires or be compliant with follow-up requirements.

研究者

发起方
Medical Device Business Services, Inc. (DePuy Synthes)

相似试验